Rights and Permissions
Rachel M Presti, Eunice Yeh, Brett Williams, Alan Landay, Jeffrey M Jacobson, Cara Wilson, Carl J Fichtenbaum, Netanya S Utay, Michael P Dube, Karin L Klingman, Jacob D Estes, Jacob K Flynn, Amanda Loftin, Jason M Brenchley, Adriana Andrade, Douglas W Kitch, Edgar T Overton, for the A5350 and A5352s teams, A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy, Open Forum Infectious Diseases, Volume 8, Issue 12, December 2021, ofab550, https://doi.org/10.1093/ofid/ofab550.
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact email@example.com. https://academic.oup.com/ofid/article/8/12/ofab550/6455601.
Presti, Rachel M. and et al, ,"A randomized, placebo-controlled trial assessing the effect of VISBIOME ES probiotic in people with HIV on antiretroviral therapy." Open Forum Infectious Diseases. 8,12. . (2021).